By Stewart Eisenhart, Emergo Group
DIGEMID, Peru’s medical device market regulatory agency, has rolled out new disclosure and laeling rules for medical devices that contain polyvinyl chloride (PVC) or PVC that contains DEHP (di-(2-ethylhexyl)phthalate).
The new rules (link in Spanish) require manufacturers and Peru Registration Holders (PRH) of devices already registered with DIGEMID to notify the regulator within 15 days of May 29, 2015 that their products include PVC or PVC with DEHP.
Then, by March 2016 affected companies will have to include additional labeling disclosing to users that their devices contain PVC and DEHP. Registration holders of medical devices incorporating PVC but not DEHP must add “DEHP Free” statements to their labeling and/or insert materials by that same deadline.
The new DIGEMID requirements will primarily impact manufacturers, importers and/or PRHs of devices designed to come into contact with liquids—bags and tubing for intravenous applications, for example.
Stewart Eisenhart covers medical device regulatory affairs for Emergo Group.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.